ATRA
Atara Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.37
+2.07%Forward multiples
Based on analyst estimates
- P/E forward
- 10.74x
- P/E 2026E
- —
- P/E 2027E
- 9.05x
- P/E 2028E
- 19.47x
- P/S forward
- 2.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.27x
- Price / sales
- 13.56x
- Price / cash flow
- -3.84x
Enterprise value
- Enterprise value
- $84.0M
- EV / sales
- 13.57x
- EV / EBITDA
- -6.13x
- EV / EBIT
- -5.91x
- Market cap
- $84.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026